Skip to main content

Table 2 Cox proportional hazard models comparing ADT users and nonusers with prostate cancer after matching

From: Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan

Outcomes

Before Matching

Propensity Score Matching

ADT Nonuser

ADT user

   

ADT Nonuser

ADT user

Adjusted HRa

95% CI

p-value

Event

Event

Adjusted HRa

95% CI

p-value

Event

Event

   

Primary outcome

82 (30.0)

499 (49.87)

1.332

1.051–1.687

0.0177*

82 (30.2)

114 (41.9)

1.192

0.885–1.605

0.2471

Any cause of death

37 (13.6)

375 (36.8)

2.107

1.499–2.900

< 0.0001*

37 (13.6)

85 (31.3)

1.907

1.278–2.844

0.0016*

Ischemic stroke

49 (18.0)

203 (19.9)

0.973

0.709–1.334

0.8640

49 (18.0)

45 (16.5)

0.812

0.534–1.234

0.3291

  1. HR hazard ratio, CI confidence interval
  2. * p-value < 0.05
  3. a adjusted variables included age group, comorbidities and comedications
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us